XPhyto Therapeutics Corp.: XPhyto Provides Updated Comments on Promotional and Marketing Activity
XPhyto Therapeutics Corp. (
XPhyto or the
Company ) at the request of IIROC and the Canadian Securities Exchange (the
CSE ) is providing additional comments to its news release and list of third-party providers dated January 22, 2021 with regards to recent promotional and investor relations activity (
Promotional Activity ) provided by said third-parties, in particular a newsletter published by WallStreetAlerts, on behalf of the Company.
The Company reminds investors that the best source for full disclosure about the company is the company itself, SEDAR or CSE profile pages for regulatory filings and news releases. The Company acknowledges that prior to the date of this news release, XPhyto did not comply with the CSE requirements to complete and post Form 10 Notices of Proposed Significant Transactions disclosing its contracts with the third-party providers. The Company has
XPhyto Therapeutics Corp.: XPhyto Provides Comments on Promotional and Marketing Activity
XPhyto Therapeutics Corp. (
) (
XPhyto or the
Corporation ) at the request of OTC Markets, is providing the following comments regarding recent promotional activity with respect to the Corporation.
The Corporation has been listed on the Canadian Securities Exchange from July 2019. Since that time, the Corporation has engaged various third parties to provide media, marketing and investor relations services (
Promotional Activity or Promotional Activities ). Most of the Corporation s Promotional Activities have been ongoing since listing. Most recently, the Corporation engaged Investor Channel Inc. in January 2021 to provide advertising placements and transaction services. All source materials and content for all Promotional Activity were provided by the Corporation and vetted for factual accuracy by a senior officer of the Corporation. Payment for Promotional Activities was made e